Meiyu
Lin
a,
Hongmei
Gao
ab,
Jinping
Liu
a,
Liu
Han
a,
Qinghe
Zhang
a and
Pingya
Li
*a
aSchool of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, China. E-mail: lipy@jlu.edu.cn
bChangchun University of Traditional Chinese Medicine, Changchun, Jilin 130021, China
First published on 28th September 2022
Correction for ‘UPLC-MS/MS determination and pharmacokinetic study of 26-OH-panaxadiol in rat plasma’ by Meiyu Lin et al., Anal. Methods, 2013, 5, 6656–6662, https://doi.org/10.1039/C3AY41320A.
In ref. 1, the authors reported the pharmacokinetics of Pseudoginsengenin DQ in rat plasma, while in this Analytical Methods article, the pharmacokinetics of 26-OH-panaxadiol were reported. The two compounds have the same basic skeleton, but different side links, one with a five-membered ring and the other with a six-membered ring. Although the structures are similar, the pharmacokinetic parameters are different as six- and five-membered side-chain drugs led to different behaviour in rats. However, as both articles reported similar protocols, ref. 1 should have been cited in this Analytical Methods article.
The authors regret that there is unattributed overlap in text between this Analytical Methods paper and ref. 1.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2022 |